CAR T-Cell Therapy in India
India's first indigenous CAR T-cell therapy, NexCAR19, approved in 2023, marks a transformative milestone in cancer treatment. Offering world-class therapy at a fraction of international costs, India is emerging as a global leader in advanced immunotherapy.
Explore Treatment Centers
Overall Response Rate in Clinical Trials
Cost in India vs $500,000 in USA
Hospitals Offering CAR T-Cell Therapy
Success Rate in Pediatric Cases
CAR T-Cell Therapy Journey in India
India's remarkable progress in CAR T-cell therapy development and implementation
Research Initiation
IIT Bombay and Tata Memorial Hospital begin collaborative research on developing India's first indigenous CAR T-cell therapy.
Clinical Trials Commence
Phase I/II clinical trials begin with 60 patients suffering from lymphomas and leukemia, showing promising early results.
Historic Approval
CDSCO grants approval to NexCAR19, making it India's first licensed CAR T-cell therapy for relapsed/refractory B-cell malignancies.
Nationwide Implementation
Therapy becomes available in 6 major hospitals across Delhi, Mumbai, and Pune, expanding access to advanced cancer treatment.
Expanding Applications
Research expands to include solid tumors and earlier treatment lines, with increased manufacturing capacity and reduced costs.
Top Hospitals for CAR T-Cell Therapy
Leading medical institutions offering advanced CAR T-cell therapy in India
Tata Memorial Hospital
Pioneer in India's CAR T-cell therapy development with world-class cancer care facilities and extensive research programs.
Apollo Cancer Institute
Comprehensive cancer care center with advanced technology and personalized treatment approaches including CAR T-cell therapy.
National Cancer Institute (AIIMS)
Premier government institution offering CAR T-cell therapy at affordable costs with cutting-edge research facilities.
Leading CAR T-Cell Therapy Specialists
Expert oncologists pioneering advanced immunotherapy in India
Dr. T Raja
25+ years of experience in cancer treatment, leading the DNB Medical Oncology program at Apollo Specialty Hospital.
Dr. Srikanth M
Expert in blood-related conditions including myeloma, B-cell lymphomas, and leukemia with award-winning research.
Dr. Revathi Raj
India's leading expert in pediatric bone marrow transplants with over 2000 successful procedures.
CAR T-Cell Therapy Process
Step-by-step journey from consultation to recovery
Consultation & Evaluation
Comprehensive medical assessment and eligibility determination for CAR T-cell therapy.
T-Cell Collection
White blood cells including T-cells are collected through leukapheresis procedure.
Genetic Modification
T-cells are engineered in specialized labs to express chimeric antigen receptors.
Infusion & Monitoring
Modified CAR T-cells are infused back into the patient with close monitoring.
Recovery & Follow-up
Post-treatment care and long-term monitoring for optimal outcomes.
Potential Side Effects & Management
Understanding and managing treatment-related effects
Cytokine Release Syndrome (CRS)
Most common side effect causing flu-like symptoms, fever, fatigue. Managed with medications like tocilizumab.
Neurological Effects
May include confusion, seizures, or encephalopathy. Typically temporary and manageable with medical supervision.
Low Blood Cell Counts
Temporary reduction in blood cells requiring monitoring and potential transfusions or growth factors.
Infection Risk
Increased susceptibility to infections requiring preventive medications and close monitoring.
Frequently Asked Questions
Common queries about CAR T-Cell therapy in India
Begin Your CAR T-Cell Therapy Journey
Connect with India's leading cancer specialists and explore advanced treatment options tailored to your specific condition. Our team will guide you through every step of the process.
Schedule a Free Consultation